Kaveri Pohlman Stock Analyst Profile - Clear Street Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kaveri Pohlman

    Stock Analyst at Clear Street

    (2.86)
    # 3053
    Out of 5,506 analysts
    32
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Medical - Pharmaceuticals

    21 Stocks

    Name Action PT Current % Upside Ratings Updated
    VTYX Ventyx Biosciences
    Initiates Coverage On: Buy
    11
    		3.6 205.56% 1 Oct 1, 2025
    RAPT RAPT Therapeutics
    Maintains: Strong Buy
    24 41
    		30.14 36.03% 1 Sep 30, 2025
    ORKA Oruka Therapeutics
    Maintains: Buy
    46 46
    		n/a n/a 1 Sep 17, 2025
    AVBP ArriVent BioPharma
    Initiates Coverage On: Buy
    32
    		19.84 61.29% 1 Jun 25, 2025
    MGNX Macrogenics
    Downgrades: Neutral
    n/a
    		n/a n/a 4 Aug 1, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    46 47
    		33.56 40.05% 3 Jun 27, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    20 30
    		5.9 408.47% 2 Apr 17, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    56 38
    		11.77 222.85% 1 Apr 16, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    5
    		3.71 34.77% 2 Mar 26, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    62
    		24 158.33% 1 Mar 21, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    8
    		2.57 211.28% 1 Feb 9, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    27
    		40.09 -32.65% 1 Dec 19, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    26
    		n/a n/a 1 Sep 12, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    70
    		13.36 423.95% 1 Aug 23, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Nov 14, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    12
    		2.35 410.64% 1 Aug 31, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    16 8
    		3.3 142.42% 2 Jul 7, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    125
    		n/a n/a 1 Jun 1, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Apr 20, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    100
    		n/a n/a 1 Feb 24, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12320 4928
    		5.63 87431.08% 2 Feb 9, 2022